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Dear Editor,
I read, with great interest, the article that you pub-
lished in your journal entitled; a comparative study of
the amount of bleeding and hemodynamic changes be-
tween dexmedetomidine infusion and remifentanil infu-
sion for controlled hypotensive anesthesia in lumbar dis-
copathy surgery (1). In their study, Javaherforooshzadeh
et al. concluded that administration of dexmedetomi-
dine plus propofol, in comparison with remifentanil plus
propofol, did not show any significant difference regard-
ing blood loss and hemodynamic changes. They adminis-
trated dexmedetomidine infusion at 0.3 - 0.7µg/kg/h intra-
operatively (1). In the study by Gousheh et al. on the ef-
fect of dexmedetomidine to prevent bleeding during func-
tional endoscopoic sinus surgery (FESS), they observed
that intravenous infusion of dexmedetomidine, during
the FESS, reduced the amount of bleeding more signifi-
cantly. In addition, they administered 1 µg/kg dexmedeto-
midine during 10 minutes just before the induction and
then infusion 0.5 µg/kg/h, intraoperatively (2). Further-
more, they used dexmedetomidine loading dose with in-
fusion dose plus remifentanil and propofol in FESS in com-
parison with the above article where only infusion dose
of dexmedetomidine with propofol are administered. The
results of this study was in contrast with the above arti-
cle that may be due to different drugs, different dosage
of drugs, or different surgeries. Rokhtabnak et al. com-
pared the effect of dexmedetomidine with magnesium sul-
fate on controlled hypotension during rhinoplasty. They
showed that dexmedetomidine was more effective than
magnesium to controlled hypotension and provide a fa-
vorable surgical field condition (3). In this study, patients
received 1µg/kg dexmedetomidinein 10 minutes before in-
duction of anesthesia, followed by 0.4 - 0.6 µg/kg/h dur-
ing the maintenance of anesthesia. Taghipour Anvari et
al. evaluated the effect of clonidine premedication on
blood loss in spine surgery and the results demonstrated
that clonidine can reduce surgical blood loss in lumbar
spine posterior fusion surgery, even at the same levels of
mean arterial pressure with the control group (4). Pa-
tients received a 200 µg oral clonidine tablet 60 - 90 min-
utes before anesthesia. Dexmedetomidine is an anxiety
reducing, sedative, and pain medication. It is an agonist
of a 2 -adrenergic receptor, that is capable to reduce the
mean arterial pressure (MAP) and heart rate (1). I think
the study of Javaherforooshzade did not show any signif-
icant differences in blood loss and hemodynamic changes
between dexmedetomidine with remifentanil due to the
fact that they compared dexmedetomidine plus propofol
with remifentanil plus propofol, where they have potent
hypotensive properties as well administered dexmedeto-
midine infusion without a loading dose. Other things such
as dosage of anesthetic drugs, range of hydration before
the induction of anesthesia, kind of surgery, and position
of patient may explain the differences between the studies.
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